| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 3578- | CUR, | SIL, | Curcumin, but not its degradation products, in combination with silibinin is primarily responsible for the inhibition of colon cancer cell proliferation |
| - | in-vitro, | CRC, | DLD1 |
| 3577- | CUR, | Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study |
| - | Trial, | AD, | NA |
| 3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
| - | Review, | AD, | NA |
| 3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
| - | Review, | AD, | NA |
| 3590- | CUR, | The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern? |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4829- | CUR, | Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective |
| - | Review, | Var, | NA |
| 4826- | CUR, | The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management |
| - | Review, | Var, | NA |
| 4655- | CUR, | Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells |
| - | in-vitro, | BC, | NA |
| 4651- | CUR, | Targeting cancer stem cells by curcumin and clinical applications |
| - | Review, | Var, | NA |
| 4672- | CUR, | An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes |
| - | vitro+vivo, | CRC, | HCT116 |
| 146- | CUR, | EGCG, | Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 |
| 125- | CUR, | Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway |
| - | in-vitro, | adrenal, | H295R |
| 1487- | CUR, | Relationship and interactions of curcumin with radiation therapy |
| - | Review, | Var, | NA |
| 6206- | CUR, | Bioavailability of Oral Curcumin in Systematic Reviews: A Methodological Study |
| - | Review, | Nor, | NA |
| 6207- | CUR, | Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6227- | CUR, | Revisiting Curcumin in Cancer Therapy: Recent Insights into Molecular Mechanisms, Nanoformulations, and Synergistic Combinations |
| - | Review, | Var, | NA |
| 6211- | CUR, | The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer |
| - | Review, | Var, | NA |
| 6214- | CUR, | Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve |
| - | Review, | CardioV, | NA |
| 6215- | CUR, | Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer |
| - | Review, | Var, | NA |
| 6216- | CUR, | Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials |
| - | Review, | Var, | NA |
| 6230- | CUR, | Dual redox effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidene) cyclohexanone (BHMC) on human liver cancer cells, HepG2 via ROS, glutathione and Nrf2/Keap1 pathway |
| - | in-vitro, | Liver, | HepG2 |
| 6228- | CUR, | A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability |
| - | Study, | Nor, | NA |
| 6222- | CUR, | Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials |
| - | Review, | Var, | NA |
| 6221- | CUR, | Oxidative Stress and Cancer: Harnessing the Therapeutic Potential of Curcumin and Analogues Against Cancer |
| - | Review, | Var, | NA |
| 6219- | CUR, | Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action |
| - | Review, | Var, | NA |
| 6218- | CUR, | Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications |
| - | Review, | Var, | NA |
| 6209- | CUR, | Curcumin as a complementary treatment in oncological therapy: a systematic review |
| - | Review, | Var, | NA |
| 6770- | CUR, | A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin |
| - | Review, | Nor, | NA |
| 2305- | CUR, | Mitochondrial targeting nano-curcumin for attenuation on PKM2 and FASN |
| - | in-vitro, | BC, | MCF7 |
| 2308- | CUR, | Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells |
| - | in-vitro, | Liver, | HepG2 |
| 2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2654- | CUR, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
| - | Review, | Var, | NA |
| 2817- | CUR, | Neuroprotection by curcumin: A review on brain delivery strategies |
| - | Review, | Nor, | NA |
| 2809- | CUR, | Comparative absorption of curcumin formulations |
| - | in-vivo, | Nor, | NA |
| 2814- | CUR, | Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management |
| - | Review, | Var, | NA |
| 2816- | CUR, | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 9098- | CV, | A Single Dose of Marine Chlorella vulgaris Increases Plasma Concentrations of Lutein, β-Carotene and Zeaxanthin in Healthy Male Volunteers |
| - | Study, | Nor, | NA |
| 6252- | Cyc, | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance |
| - | Review, | Var, | NA |
| 6686- | DAP, | Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer |
| - | in-vivo, | Pca, | NA |
| 6591- | DAS, | Dasatinib in solid tumors |
| - | Review, | Var, | NA |
| 6590- | DAS, | Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells |
| - | in-vitro, | Pca, | NA |
| 6683- | DCA, | Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts |
| - | Review, | Var, | NA |
| 6681- | DCA, | Dichloroacetate (DCA) in Cancer Care |
| - | Review, | Var, | NA |
| 6671- | Deg, | A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy |
| - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | H460 |
| 6670- | Deg, | Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats |
| - | in-vivo, | Nor, | NA |
| 6702- | DFC, | Diclofenac |
| - | Review, | Nor, | NA |
| 6705- | DFC, | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases |
| - | Review, | Var, | NA |
| 6694- | DFC, | Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent |
| - | Review, | Var, | NA |
| 8826- | DIM, | Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3, 3′-Diindolylmethane in Healthy Subjects |
| - | Study, | Nor, | NA |
| 8829- | DIM, | Anti-androgenic activity of absorption-enhanced 3, 3’-diindolylmethane in prostatectomy patients |
| - | Human, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid